Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: Outcome at 3 years

被引:127
作者
Grazzi, L
Andrasik, F
D'Amico, D
Leone, M
Usai, S
Kass, SJ
Bussone, G
机构
[1] Natl Neurol Inst C Besta, Headache Ctr, I-20133 Milan, Italy
[2] Univ W Florida, Inst Human Machine Cognit, Pensacola, FL 32501 USA
[3] Univ W Florida, Dept Psychol, Pensacola, FL 32501 USA
来源
HEADACHE | 2002年 / 42卷 / 06期
关键词
drug-induced headache; transformed migraine; pharmacologic treatment; biofeedback-assisted relaxation treatment; long-term follow-up;
D O I
10.1046/j.1526-4610.2002.02123.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective.-To determine whether combined treatment using medication and biofeedback would be more effective than drug treatment alone for treating transformed migraine complicated by analgesic overuse. Background.-Headaches that are chronic, daily, and aggravated by medication overuse are particularly difficult to treat. Methods.-Sixty-one consecutive patients with transformed migraine and analgesic overuse were treated with inpatient pharmacologic therapy alone or with inpatient pharmacologic therapy combined with biofeedback-assisted relaxation. All patients then were followed prospectively for 3 years. Results.-Both treatment groups exhibited similar levels of improvement immediately following treatment and for 1 year thereafter. At year 3, participants receiving combined treatment showed greater sustained improvement on two of three outcome measures assessed (ie, fewer days of headache and reduced consumption of analgesic medication). In addition, a greater number of patients assigned to pharmacologic treatment alone relapsed (ie, resumed overuse of analgesics) compared to patients receiving combined treatment. Conclusions.-These results suggest that a combination of pharmacologic and behavioral treatment is more effective than drug therapy alone in the long-term management of transformed migraine with analgesic overuse. Confirmation of these findings, as well as extension to other forms of behavioral and cognitive-behavioral treatment, is required.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 37 条
[1]   ERGOTAMINE ABUSE - RESULTS OF ERGOTAMINE DISCONTINUATION, WITH SPECIAL REFERENCE TO THE PLASMA-CONCENTRATIONS [J].
ALAHURULA, V ;
MYLLYLA, V ;
HOKKANEN, E .
CEPHALALGIA, 1982, 2 (04) :189-195
[2]  
ANDRASIK F, 2001, HDB PAIN ASSESSMENT, P454
[3]  
ANDRASIK F, 1986, PAIN MANAGEMENT HDB, P213
[4]  
ANDRASIK F, IN PRESS COMPREHENSI, V9
[5]   LONGTERM PROGNOSIS OF ANALGESIC WITHDRAWAL IN PATIENTS WITH DRUG-INDUCED HEADACHES [J].
BAUMGARTNER, C ;
WESSELY, P ;
BINGOL, C ;
MALY, J ;
HOLZNER, F .
HEADACHE, 1989, 29 (08) :510-514
[6]  
Bernstein D., 1973, PROGR RELAXATION TRA
[7]   PRELIMINARY-RESULTS FROM THE SELF-REGULATORY TREATMENT OF HIGH-MEDICATION-CONSUMPTION HEADACHE [J].
BLANCHARD, EB ;
TAYLOR, AE ;
DENTINGER, MP .
BIOFEEDBACK AND SELF-REGULATION, 1992, 17 (03) :179-202
[8]   Medication-induced (analgesic rebound) headache: Historical aspects and initial descriptions of the North American experience [J].
Capobianco, DJ ;
Swanson, JW ;
Dodick, DW .
HEADACHE, 2001, 41 (05) :500-502
[9]  
DIAMOND S, 1982, PRACTICING PHYSICIAN, P114
[10]   ANALGESIC-INDUCED CHRONIC HEADACHE - LONG-TERM RESULTS OF WITHDRAWAL THERAPY [J].
DIENER, HC ;
DICHGANS, J ;
SCHOLZ, E ;
GEISELHART, S ;
GERBER, WD ;
BILLE, A .
JOURNAL OF NEUROLOGY, 1989, 236 (01) :9-14